Efficacy News and Research

RSS
MBPs offer no clinical benefit to patients undergoing PD: Research team

MBPs offer no clinical benefit to patients undergoing PD: Research team

Meda acquires exclusive rights for use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals

Meda acquires exclusive rights for use of flupirtine to treat fibromyalgia from Adeona Pharmaceuticals

Advances in combination adult stem cell treatment for acute myocardial infarction presented at SCAI

Advances in combination adult stem cell treatment for acute myocardial infarction presented at SCAI

Merrion Pharmaceuticals increases patent protection for Orazol

Merrion Pharmaceuticals increases patent protection for Orazol

Amira Pharmaceuticals' LPA1 receptor antagonist program data published in British Journal of Pharmacology

Amira Pharmaceuticals' LPA1 receptor antagonist program data published in British Journal of Pharmacology

Mouse study may lead to new therapies for Parkinson's disease

Mouse study may lead to new therapies for Parkinson's disease

FDA approves new oral contraceptive Natazia

FDA approves new oral contraceptive Natazia

Oramed reports Phase 2b non-FDA clinical trial results of ORMD-0801 oral insulin capsule

Oramed reports Phase 2b non-FDA clinical trial results of ORMD-0801 oral insulin capsule

Keryx Biopharmaceuticals commences Phase 3 registration program for Zerenex

Keryx Biopharmaceuticals commences Phase 3 registration program for Zerenex

Cytochroma reports positive results from Phase I trial for CTAP201 Injection in hemodialysis patients

Cytochroma reports positive results from Phase I trial for CTAP201 Injection in hemodialysis patients

Columbia Laboratories reports 34% increase in net revenues from U.S. sales of progesterone products

Columbia Laboratories reports 34% increase in net revenues from U.S. sales of progesterone products

Investigators demonstrate safety and efficacy of targeted medication to shrink advanced kidney cancers

Investigators demonstrate safety and efficacy of targeted medication to shrink advanced kidney cancers

Researchers demonstrate how Plasmodium falciparum can able to circumvent action of artemisinin

Researchers demonstrate how Plasmodium falciparum can able to circumvent action of artemisinin

Xience V sales out-performing Promus in Japanese drug-eluting stent market: MRG

Xience V sales out-performing Promus in Japanese drug-eluting stent market: MRG

AGA Medical first-quarter net sales increase 15.4% to $51.3 million

AGA Medical first-quarter net sales increase 15.4% to $51.3 million

New research to improve effectiveness of nicotine vaccination for cigarette smokers

New research to improve effectiveness of nicotine vaccination for cigarette smokers

Phase II trial: TB-402 demonstrates superior antithrombotic activity to enoxaparin

Phase II trial: TB-402 demonstrates superior antithrombotic activity to enoxaparin

Abbott's SPIRIT IV trial results published in The New England Journal of Medicine

Abbott's SPIRIT IV trial results published in The New England Journal of Medicine

CU-Boulder develops inhalable vaccine for measles prevention

CU-Boulder develops inhalable vaccine for measles prevention

Sermo Category Report: About 30% of patients suffer from depression

Sermo Category Report: About 30% of patients suffer from depression

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.